tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VNDA Stock Latest News

Maintaining Buy Rating on Vanda: Limited Impact from Tasimelteon Setback, Ongoing FDA Engagement, and Bysanti Catalyst Support $22 Target
RatingsMaintaining Buy Rating on Vanda: Limited Impact from Tasimelteon Setback, Ongoing FDA Engagement, and Bysanti Catalyst Support $22 Target
9d ago
VNDA
H.C. Wainwright says rejection of Vanda’s tasimelteon ‘only minor setback’
PremiumThe Fly
H.C. Wainwright says rejection of Vanda’s tasimelteon ‘only minor setback’
9d ago
VNDA
Vanda Faces FDA Setback on HETLIOZ Jet Lag Application
PremiumCompany Announcements
Vanda Faces FDA Setback on HETLIOZ Jet Lag Application
9d ago
8K
VNDA
Vanda Pharmaceuticals down 11% to $7.55 after FDA rejects sNDA for hetlioz
PremiumThe Fly
Vanda Pharmaceuticals down 11% to $7.55 after FDA rejects sNDA for hetlioz
9d ago
VNDA
Vanda Pharmaceuticals: FDA says sNDA for hetlioz can’t be approved
PremiumThe Fly
Vanda Pharmaceuticals: FDA says sNDA for hetlioz can’t be approved
9d ago
VNDA
Vanda Pharmaceuticals price target raised to $22 from $20 at H.C. Wainwright
PremiumThe FlyVanda Pharmaceuticals price target raised to $22 from $20 at H.C. Wainwright
12d ago
VNDA
Midday Fly By: Nvidia said to see strong H200 demand in China
Premium
The Fly
Midday Fly By: Nvidia said to see strong H200 demand in China
17d ago
CSX
DJT
Morning Movers: Nvidia up as report points to strong demand in China
Premium
The Fly
Morning Movers: Nvidia up as report points to strong demand in China
17d ago
H
NKE
Video: Nvidia responding to strong demand for H200 in China
PremiumThe Fly
Video: Nvidia responding to strong demand for H200 in China
17d ago
NKE
NVDA
Vanda Pharmaceuticals price target raised to $14 from $11 at B. Riley
PremiumThe Fly
Vanda Pharmaceuticals price target raised to $14 from $11 at B. Riley
17d ago
VNDA
Vanda motion sickness approval comes with ‘broad’ label, says Cantor
PremiumThe Fly
Vanda motion sickness approval comes with ‘broad’ label, says Cantor
17d ago
VNDA
Vanda Wins FDA Approval for NEREUS Motion Sickness Drug
PremiumCompany Announcements
Vanda Wins FDA Approval for NEREUS Motion Sickness Drug
17d ago
8K
VNDA
Vanda jumps 18% to $8.33 after motion sickness FDA approval
PremiumThe FlyVanda jumps 18% to $8.33 after motion sickness FDA approval
17d ago
VNDA
Vanda receives FDA approval of Nereus for motion sickness
Premium
The Fly
Vanda receives FDA approval of Nereus for motion sickness
17d ago
VNDA
Vanda Pharmaceuticals price target raised to $7.50 from $5 at Jefferies
Premium
The Fly
Vanda Pharmaceuticals price target raised to $7.50 from $5 at Jefferies
17d ago
VNDA
Vanda trading resumes
PremiumThe Fly
Vanda trading resumes
18d ago
VNDA
Vanda trading halted, news pending
PremiumThe Fly
Vanda trading halted, news pending
18d ago
VNDA
Vanda Pharmaceuticals: Promising Pipeline and Regulatory Progress Drive Buy Rating
PremiumRatings
Vanda Pharmaceuticals: Promising Pipeline and Regulatory Progress Drive Buy Rating
1M ago
VNDA
Vanda Pharmaceuticals announces submission of BLA to FDA for imsidolimab
PremiumThe Fly
Vanda Pharmaceuticals announces submission of BLA to FDA for imsidolimab
1M ago
VNDA
FDA Lifts Hold on Vanda’s Tradipitant Trials
PremiumCompany AnnouncementsFDA Lifts Hold on Vanda’s Tradipitant Trials
1M ago
8K
VNDA
FDA lifts partial clinical hold on Vanda Pharmaceuticals’ tradipitant
Premium
The Fly
FDA lifts partial clinical hold on Vanda Pharmaceuticals’ tradipitant
1M ago
VNDA
Vanda Pharmaceuticals: Buy Rating Backed by Promising Drug Pipeline and Market Potential
Premium
Ratings
Vanda Pharmaceuticals: Buy Rating Backed by Promising Drug Pipeline and Market Potential
2M ago
VNDA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >